 |
| The First Word |  Top |
|
 |
|
Please, Mr. Clinton p131
Douglas K. McCormick
doi:10.1038/nbt0293-131
PDF
(116K)
|
|
| Correspondence | Top |
|
|
|
Lonely Too Long p132
Richard Wilkinson
doi:10.1038/nbt0293-132a
PDF
(100K)
|
|
|
|
A Dubious Measure p132
Gordon Moore
doi:10.1038/nbt0293-132b
PDF
(100K)
|
|
| Commentary | Top |
|
|
|
Bureaucracy, Brussels-Style p135
Bernard Dixon
doi:10.1038/nbt0293-135
PDF
(109K)
|
|
| News Briefs | Top |
|
|
|
News Briefs pp136 - 141
doi:10.1038/nbt0293-136
PDF
(371K)
|
|
| News Analysis | Top |
|
|
|
PTO reexamines Roche's alpha-interferon patent pp143 - 144
Jeffrey L. Fox
doi:10.1038/nbt0293-143
PDF
(228K)
|
|
|
|
Immunex/Cyanimid merger focuses on cancer pp144 - 146
B. J. Spalding
doi:10.1038/nbt0293-144
PDF
(231K)
|
|
|
|
Stock-exchange proposals disappoint U.K. firms pp146 - 147
Mike Ward
doi:10.1038/nbt0293-146
PDF
(235K)
|
|
|
|
Biotech stocks won't heat up this year pp148 - 149
Jeffrey Casdin
doi:10.1038/nbt0293-148
PDF
(239K)
|
|
|
|
1992 financing nets $2 billion p149
B. J. Spalding
doi:10.1038/nbt0293-149
PDF
(122K)
|
|
|
|
R&D alliances give biggest bang for buck p150
Joseph Alper
doi:10.1038/nbt0293-150
PDF
(126K)
|
|
|
|
Shelved by Campbell, Calgene retreats at FDA pp152 - 153
Russ Hoyle
doi:10.1038/nbt0293-152
PDF
(240K)
|
|
|
|
Thrombolytic survival test p153
Jeffrey L. Fox
doi:10.1038/nbt0293-153
PDF
(130K)
|
|
|
|
Thioredoxin fusions eliminate E. coli inclusions p154
Harvey Bialy
doi:10.1038/nbt0293-154a
PDF
(122K)
|
|
|
|
IOM endorses FDA advisory-committee system pp154 - 155
Jeffrey L. Fox
doi:10.1038/nbt0293-154b
PDF
(232K)
|
|
|
|
Biology and chemical engineering bond p155
Douglas Lauffenburger
doi:10.1038/nbt0293-155
PDF
(127K)
|
|
|
|
Have monoclonals fulfilled their promise? pp156 - 157
Paul Abrams
doi:10.1038/nbt0293-156
References | PDF
(237K)
|
|
| Articles | Top |
|
|
|
Prestidigitation in the Clinic pp159 - 162
John Hodgson
doi:10.1038/nbt0293-159
Abstract + references | PDF
(792K)
|
|
|
|
Empiricism Strikes Back: Neural Networks in Biotechnology pp163 - 166
Mark Collins
doi:10.1038/nbt0293-163
Abstract + references | PDF
(609K)
|
|
|
|
Biopharmaceuticals Go to Market: Patterns of Worldwide Development pp168 - 172
Brigitta Bienz-Tadmor
doi:10.1038/nbt0293-168
Abstract + references | PDF
(479K)
|
|
|
|
Virus Harvesting and Affinity-Based Liquid Chromatography pp173 - 178
P. F. O'Neil
& E. S. Balkovic
doi:10.1038/nbt0293-173
Abstract + references | PDF
(886K)
|
|
| Book Review | Top |
|
|
|
Biotechnology and the Public Interest pp180 - 181
Rollin B. Johnson
doi:10.1038/nbt0293-180
PDF
(247K)
|
|
| Review | Top |
|
|
|
Processing of Protein Precursors by a Novel Family of Subtilisin-Related Mammalian Endoproteases pp182 - 186
Steven P. Smeekens
doi:10.1038/nbt0293-182
Abstract + references | PDF
(640K)
|
|
| Research | Top |
|
|
|
A Thioredoxin Gene Fusion Expression System That Circumvents Inclusion Body Formation in the E. coli Cytoplasm pp187 - 193
Edward R. LaVallie, Elizabeth A. DiBlasio, Sharlotte Kovacic, Kathleen L. Grant, Paul F. Schendel
& John M. McCoy
doi:10.1038/nbt0293-187
Abstract + references | PDF
(958K)
|
|
|
|
Field Performance of Elite Transgenic Maize Plants Expressing an Insecticidal Protein Derived from Bacillus thuringiensis pp194 - 200
Michael G. Koziel, Gary L. Beland, Cindy Bowman, Nadine B. Carozzi, Rebecca Crenshaw, Lyle Crossland, John Dawson, Nalini Desai, Martha Hill, Sue Kadwell, Karen Launis, Kelly Lewis, Daryl Maddox, Kathryn McPherson, Moez R. Meghji, Ellis Merlin, Richard Rhodes, Gregory W. Warren, Martha Wright
& Stephen V. Evola
doi:10.1038/nbt0293-194
Abstract + references | PDF
(1,206K)
|
|
|
|
A Streptavidin Mutant Containing a Cysteine Stretch That Facilitates Production of a Variety of Specific Streptavidin Conjugates pp201 - 206
Takeshi Sano, Cassandra L. Smith
& Charles R. Cantor
doi:10.1038/nbt0293-201
Abstract + references | PDF
(808K)
|
|
|
|
A Novel Process for the Large-Scale Purification of Recombinant Tick Anticoagulant Peptide Using Perfusion Chromatography pp207 - 212
E. Dale Lehman, Joseph G. Joyce, Daniel K. Freymeyer II, F. James Bailey, Wayne K. Herber
& William J. Miller
doi:10.1038/nbt0293-207
Abstract + references | PDF
(771K)
|
|
|
|
Selective Release of Recombinant Protein Particles (VLPs) from Yeast Using a Pure Lytic Glucanase Enzyme pp214 - 217
J. A. Asenjo, A. M. Ventom, R. -B. Huang
& B. A. Andrews
doi:10.1038/nbt0293-214
Abstract + references | PDF
(624K)
|
|
|
|
Selectable Marker Genes Engineered for Specific Expression in Target Cells for Plant Transformation pp218 - 221
Sebahattin Özcan, Simon Firek
& John Draper
doi:10.1038/nbt0293-218
Abstract + references | PDF
(530K)
|
|
| Reader Service | Top |
|
|
|
| Diagnostic Kits |
|
|
|
Diagnostic Kits p222
doi:10.1038/nbt0293-222
PDF
(149K)
|
|
 |
|
| New Products |
|
|
|
New Products pp223 - 224
doi:10.1038/nbt0293-223
PDF
(219K)
|
|
|
|
| Free Literature |
|
|
|
Free Literature p226
doi:10.1038/nbt0293-226
PDF
(165K)
|
|
| Announcements | Top |
|
|
|
Announcements p235
doi:10.1038/nbt0293-235
PDF
(101K)
|
|
| The Last Word | Top |
|
|
|
Is It Really Environmentalism Versus Biotechnology? p236
Walter Truett Anderson
doi:10.1038/nbt0293-236
PDF
(111K)
|
|
|
Top |
|
|
